FBR Capital Maintains an 'Outperform' Rating on Healthways (HWAY); The Day Has Come
Tweet Send to a Friend
FBR Capital maintains an 'Outperform' rating on Healthways (NASDAQ: HWAY), PT $17.
FBR analyst says, "We continue to recommend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "We continue to recommend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
